October 2022
Dosis NewsDosis Demonstrates 40% Reduction in Epoetin Beta Utilization with Maintained Hemoglobin Levels
Dosis, a market leader in artificial intelligence-powered precision dosing, announced today the publication of two ...
Deliver AI-powered personalized dosing recommendations for your patients.
Unlike conventional dosing approaches which assume each patient is an average drug responder, the Dosis platform leverages artificial intelligence and control algorithms to determine a patient’s unique response to a medication and deliver optimal dose recommendations.
Use less drug to achieve equivalent or improved patient outcomes. An increase in dose efficiency means lowered drug exposure for patients and lowered costs for clinics.
Decrease the likelihood of serious adverse events by decreasing patient exposure to drugs. Higher doses are associated with a higher likelihood of adverse events.
Dosis is a cloud-based clinical decision support platform that uses artificial intelligence and control algorithms to personalize drug dosing.
Generates personalized recommendations to keep patients within a specified therapeutic range
Empowers clinicians to use dramatically less medication to achieve the same or better patient outcomes
Used in clinics across the United States, and backed by years of peer-reviewed research
Used in over 30 million treatments, SAA personalizes drug dosing for erythropoiesis-stimulating agents (ESAs), a class of drugs used to treat dialysis patients with chronic anemia.
Clinics that use SAA achieve equivalent or improved hemoglobin outcomes while using dramatically less drug, resulting in reduced patient drug exposure and reduced drug cost.
We earn when you save. Our pricing model is built on aligned incentives, and we only charge a portion of the savings you realize.
October 2022
Dosis NewsDosis, a market leader in artificial intelligence-powered precision dosing, announced today the publication of two ...
October 2022
Dosis NewsClinical Information Management Finalist Strategic Anemia Advisor Dosis Inc. ...
May 2022
Dosis NewsDosis, a market leader in artificial intelligence-powered precision dosing, announced today the implementation of its ...